Please login to the form below

Strides Arcolab

This page shows the latest Strides Arcolab news and features for those working in and with pharma, biotech and healthcare.

Cipla, Cadila Healthcare, Hetero, Strides Arcolab, Ranbaxy, Sequent Scientific and Mylan) at a 7% royalty rate.

Sovaldi deal for developing world ‘falls short’

Strides Arcolab - include some of the world's largest generic players, reports the Pharmalot blog.
Pfizer inks $360m deal to buy InnoPharma

Last year, generics giant Mylan made a big leap forward in the sector with a $1.6bn agreement to buy Strides Arcolab's sterile injectables unit Agila, while Becton Dickinson has
Hikma to retain injectables unit

Hikma said in March it decided to look into the future of the division after being sent unsolicited offers in the wake of Mylan's $1.6bn deal to acquire Strides ... Arcolab's injectables unit.
Injectables land-grab set to continue as Hikma reports offers

Hikma has said it is looking into the future of its injectable drugs unit after overtures from possible buyers, just days after Mylan agreed a $1.6bn deal to buy Strides ... Mylan said when it announced its deal for Strides Arcolab's Agila unit that it
Mylan agrees $1.6bn deal to buy Agila injectables unit

Generics firm becomes “top three player” in injectables. Consolidation continues apace in the generics sector, with Mylan agreeing a $1.6bn deal to acquire Strides Arcolab of India's sterile injectables

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Pharma deals in May 2015

360. Aspen/ Strides Arcolab. Divestment. Range of branded and generic drugs.
Deal Watch table for September 2014

200. Shasun / Strides Arcolab. Company acquisition. Shasun is an Indian API and generic company.
Pharma deals during September 2014

year. In India this month, Strides Arcolab has acquired another Indian generic and API supplier Shasun in an all stock deal worth $200m to add products to its portfolio.
The rise of chronic disease in BRIC markets

with Strides Arcolab to jointly manufacture and distribute generic cancer drugs in developing markets.
Pharma deals during February 2013

Geographic expansion and consolidation. Mylan, the generics giant, has announced a trio of deals with Indian companies this month. In the largest, it announced its planned acquisition of Strides Arcolab's

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Add my company

Healthcare communications with unique thinking, insight and attitude...

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...